Heart transplant remains the therapy of choice for patients with end-stage heart failure but is limited by chronic shortage of donated organs. Mechanical circulatory support (MCS) devices, with modern designs, have been used as destiny therapy, yielding better results that have positively impacted patient survival. The indications for MCS have significantly increased and become part of the current context of potential candidates for transplant, be it as destiny therapy, bridge-to-transplant or bridge-to candidacy. However, there remains a considerable number of […]
